Results 221 to 230 of about 1,647,355 (316)

Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer

, 2016
Bo Ai, Huiquan Liu, Yu Huang, Ping Peng
openalex   +1 more source

Iron homeostasis disruption and lipid peroxidation in skeletal muscle during short‐term immobilization

FEBS Open Bio, EarlyView.
14‐day casting‐induced immobilization reduced gastrocnemius muscle mass and increased non‐heme iron and ferritin heavy chain levels. Despite iron accumulation, transferrin receptor 1 and iron regulatory protein 2 were paradoxically upregulated. Lipid peroxidation was elevated without compensatory antioxidant responses.
Haruka Yokogawa, Kazuhiko Higashida, Naoya Nakai   +2 more
wiley   +1 more source

Reduction in Donor-Derived Cell-Free DNA After Rejection Treatment is Associated With Improved Long Term Allograft Function. [PDF]

Clin Transplant
Schumacher L, Philippart O, Yau J, Shuaib F, Paluri S, Castellanos AL, Schadler A, Fattah H.   +7 more
europepmc   +1 more source

Data Sheet 1_Detection of lung allograft injury through a comprehensive multidisciplinary analysis of donor-derived cell-free DNA in plasma and bronchoalveolar lavage: a real-world single center experience.docx

Fiorella Calabrese (8732), Federica Pezzuto (11034759), Luca Vedovelli (9688365), Cecilia De Chellis (22188988), Francesca Lunardi (383509), Monica Loy (21086198), Eleonora Faccioli (22188991), Marta Vadori (22037888), Davide Biondini (2736265), Serena Marinello (11960646), Fausto Braccioni (6810755), Federica Meloni (2377684), Marco Schiavon (3777040), Chiara Giraudo (9361718), Claudia Del Vecchio (6104636), Deborah J. Levine (22188994), Emanuele Cozzi (9407893), Federico Rea (383513)   +17 more
openalex   +1 more source

Proteasomal degradation of intracellularly expressed Amblyomin‐X limits suicide gene therapy potential in melanoma cells

FEBS Open Bio, EarlyView.
This study explores the feasibility of expressing the antitumoral protein Amblyomin‐X through a suicide gene therapy approach and investigates its intracellular fate after gene delivery. Although the gene is efficiently expressed, melanoma cells rapidly degrade the Amblyomin‐X protein via proteasome activity.
Victor Dal Posolo Cinel, Carlos DeOcesano Pereira, Aline Ramos Maia Lobba, Melissa Regina Fessel, Ana Marisa Chudzinski‐Tavassi   +4 more
wiley   +1 more source

TP53 mutations on circulating cell-free DNA

EBioMedicine, 2016
Klaus Pantel
doaj   +1 more source

Beyond Circulating Tumor DNA for Efficacy: Can We Use Cell-Free DNA to Detect and Monitor Toxicity Signals? [PDF]

JCO Precis Oncol
Zhao Y, Gallon J, Kushner MH, Jakubison B, Reis-Filho JS, Hodgson D, Elvin J, Dor Y, Hadfield J.   +8 more
europepmc   +1 more source

Referee report. For: Donor-derived circulating cell-free DNA as a rejection biomarker and modulator of immunosuppression following liver transplantation: A randomized controlled trial [version 1; peer review: 1 approved]

Roma Raj
openalex   +1 more source

MiR‐513a promotes human erythroid differentiation by modulating c‐Jun

FEBS Open Bio, EarlyView.
During early human erythropoiesis, miR‐513a promoted erythroid differentiation in primary human CD34+ hematopoietic stem‐progenitor cells and human TF‐1 erythroleukemic cells by indirectly decreasing c‐Jun and phospho‐c‐Jun expression, which are associated with increased GATA1 expression.
MinJung Kim, Brittany Taylor, Shannon Bolten, Christian L. Eberly, Mahliya Abdurahman, T. Michael Creed, Acong Yang, Taylor L. Hatchet, Tristan Dyson, Shuo Gu, Curt I. Civin, Tami J. Kingsbury   +11 more
wiley   +1 more source

Circulating cell-free DNA in hematological malignancies

Haematologica, 2016
Lieselot Buedts, Peter Vandenberghe
doaj   +1 more source